Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 07 Oct 2026 for Acrivon Therapeutics, Inc., €521. Read the official filing
Filing timeline
BuySaleMary Miller
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Mary Miller: trading record in brief
Mary Miller, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Acrivon Therapeutics, Inc. and Butterfly Network, Inc. We count 30 filings; the first trade dates from 16 February 2022 and the latest from 5 October 2026.
No open-market purchase appears, only 4 sales worth €89k. The rest of the record consists of 26 share grants. Since January 2026: no purchases and 3 sales on the market.
The newest entry dates from 7 October 2026: an open-market sale of €521, in Acrivon Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mary Miller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
294 shares@ US$1.99Common StockSEC:0000905148-26-004399:0
185 shares@ US$2.010.0004% mcap0.6% of flowCommon StockSEC:0000905148-26-003839:0
573 shares@ US$1.760.0011% mcap1.8% of flowCommon StockSEC:0000905148-26-003334:0
558 shares@ US$1.781.7% of flowCommon StockSEC:0000905148-26-001768:0
217 shares@ US$1.630.6% of flowCommon StockSEC:0000905148-26-000937:0
659 shares@ US$1.982.3% of flowCommon StockSEC:0000905148-26-000281:0
184 shares@ US$2.240.7% of flowCommon StockSEC:0000905148-25-004130:0
558 shares@ US$1.811.7% of flowCommon StockSEC:0000905148-25-003637:0
284 shares@ US$1.810.9% of flowCommon StockSEC:0000905148-25-003506:0
184 shares@ US$1.390.4% of flowCommon StockSEC:0000905148-25-003042:0
558 shares@ US$1.321.3% of flowCommon StockSEC:0000905148-25-002493:0
184 shares@ US$1.140.4% of flowCommon StockSEC:0000905148-25-001823:0
558 shares@ US$1.811.8% of flowCommon StockSEC:0000905148-25-001257:0
217 shares@ US$5.422.3% of flowCommon StockSEC:0000905148-25-000729:0
659 shares@ US$5.787.5% of flowCommon StockSEC:0000905148-25-000168:0
184 shares@ US$7.922.8% of flowCommon StockSEC:0000905148-24-003227:0
558 shares@ US$7.878.2% of flowCommon StockSEC:0000905148-24-002773:0
284 shares@ US$6.983.6% of flowCommon StockSEC:0000905148-24-002637:0
184 shares@ US$7.022.4% of flowCommon StockSEC:0000905148-24-002282:0
558 shares@ US$7.697.9% of flowCommon StockSEC:0001140361-24-033600:0
184 shares@ US$8.362.9% of flowCommon StockSEC:0000905148-24-001493:0
558 shares@ US$10.3411.0% of flowCommon StockSEC:0000905148-24-001186:0
217 shares@ US$3.401.4% of flowCommon StockSEC:0000905148-24-000765:0
652 shares@ US$4.355.3% of flowCommon StockSEC:0000905148-24-000240:0
735 shares@ US$5.087.1% of flowCommon StockSEC:0000905148-23-001477:0
25 of 30 declarations
